List view / Grid view
Stability attributes of biologic candidates are evaluated during early development workflows. Learn how to measure them with biophysical techniques.
The decisions you make about your biologics candidates early in the pipeline ultimately affect their success as therapeutics. Combine sizing and stability information to develop successful biologics.
Learn how Dianthus resolves common challenges you face during the characterization of PROTAC binary and ternary complexes and the determination of cooperativity.
Learn about DLS, a powerful method to characterise the purity and aggregation state of your biologics for improved candidate selection.
NanoTemper Technologies launches Spectral Shift, a breakthrough technology that changes the game for affinity-based screenings
NanoTemper Technologies has announced the launch of Spectral Shift technology with its Dianthus instrument.
Learn why measuring binding affinity is key to helping you decide the next steps in your research and what technologies are available to measure it.
Learn how to measure protein stability, why it’s important, and what the key technologies are available to measure it.
Learn how fragment-based drug discovery improves hit rates and delivers higher-value targets using various biophysical methods.
Learn why researchers turned to biophysical methods to expose the molecular mechanisms of neurodegenerative diseases.
Application note: Faster and more reliable quantification of oligonucleotide interaction with human serum albumin using MST
Antisense oligonucleotides are an emerging therapeutic option for treating diseases with known genetic origin.
Current technologies that measure molecular interactions for drug discovery slow down and complicate screening. Dianthus is the answer to the demands for fast, non-stop, highly sensitive hit identification, hit validation and lead optimisation.